UY28762A1 - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
UY28762A1
UY28762A1 UY28762A UY28762A UY28762A1 UY 28762 A1 UY28762 A1 UY 28762A1 UY 28762 A UY28762 A UY 28762A UY 28762 A UY28762 A UY 28762A UY 28762 A1 UY28762 A1 UY 28762A1
Authority
UY
Uruguay
Prior art keywords
new compounds
therapy
preparation
pharmaceutical compositions
compounds
Prior art date
Application number
UY28762A
Other languages
English (en)
Inventor
Johansson Martin-Malmstrom
Jonas-Minidis
Alexander-Nilsson
Karolina-Wensbo
Andreas-Osterlund
Krister Andreas
Original Assignee
Astrazeneca Ab
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Nps Pharma Inc filed Critical Astrazeneca Ab
Publication of UY28762A1 publication Critical patent/UY28762A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos compuestos, un proceso para su preparación, su uso en terapia y composiciones farmacéuticas que comprenden dichos nuevos compuestos.
UY28762A 2004-02-20 2005-02-18 Nuevos compuestos UY28762A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54590504P 2004-02-20 2004-02-20

Publications (1)

Publication Number Publication Date
UY28762A1 true UY28762A1 (es) 2005-08-31

Family

ID=34910738

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28762A UY28762A1 (es) 2004-02-20 2005-02-18 Nuevos compuestos

Country Status (4)

Country Link
AR (1) AR047967A1 (es)
TW (1) TW200538180A (es)
UY (1) UY28762A1 (es)
WO (1) WO2005082884A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2001849T3 (pl) * 2006-03-29 2015-04-30 Hoffmann La Roche Pochodne pirydyny i pirymidyny jako antagoniści mGluR2
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922735A1 (de) * 1989-07-11 1991-01-24 Hoechst Ag Aminopyrimidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
DE4029649A1 (de) * 1990-09-19 1992-03-26 Hoechst Ag Alkoxypyridyl-pyrimidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als fungizide
WO2001051045A2 (en) * 2000-01-13 2001-07-19 Tularik Inc. Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia

Also Published As

Publication number Publication date
WO2005082884A3 (en) 2006-05-18
AR047967A1 (es) 2006-03-15
WO2005082884A2 (en) 2005-09-09
TW200538180A (en) 2005-12-01

Similar Documents

Publication Publication Date Title
UY30304A1 (es) Moduladores de mglur5 i
CR8717A (es) Nuevos compuestos
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
UY30308A1 (es) Moduladores de mglur5 v
UY30307A1 (es) Moduladores de mglur5 vi
UY27720A1 (es) Aroilpiridinonas monocíclicas,
UY30306A1 (es) Moduladores de mglur5 iii
CL2008002319A1 (es) Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
UY28342A1 (es) Nuevos compuestos
AR061348A1 (es) Preparados estables de laquinimod
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
ECSP077999A (es) Formulaciones de una sal de bupropion de liberación modificada
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
ES2422556T3 (es) Tratamiento de hepatitis vírica
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
BRPI0611956A2 (pt) composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
UY28348A1 (es) Compuestos novedosos
CR7828A (es) Oxialquilamidas de quinolina, isoquinolina y quinazolina y su uso como fungicidas
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
UY30309A1 (es) Moduladores de mglur5 ii
CL2008001323A1 (es) Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
NO20082376L (no) Farmasoytiske sammensetninger
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
CR9786A (es) Compuestos de bencimidazol-tiofeno